Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 14, 2019VaccineOpen Access

Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia—Results of a phase 1/2 randomized, double-blinded, controlled trial

View Full Paper
Ask AI
Bookmark
Share

Authors

ECEd ClarkeLondon School of Hygiene & Tropical MedicineABAdedapo Olufemi BashorunLondon School of Hygiene & Tropical MedicineMOMichael OkoyeMRC Unit the Gambia

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Clarke et al. (2019) studied this question.

synapsesocial.com/papers/69fcd1907557000cffdefdaahttps://doi.org/10.1016/j.vaccine.2019.08.072
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Safety and Reactogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) When Coadministered With Routine Childhood Vaccines2009 · 90 citations
  2. 2Interval estimation for the difference between independent proportions: comparison of eleven methods1998 · 1,879 citations
  3. 3Global, regional, and national burden of meningitis, 1990–2016: a systematic analysis for the Global Burden of Disease Study 20162018 · 394 citations
  4. 4Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–152018 · 1,183 citations